TONIX PHARMACEUTICALS HOLDIN (TNXP) Institutional Ownership and Insiders Activity

TONIX PHARMACEUTICALS HOLDIN (TNXP) is widely held by institutional investors, with 100 firms reporting positions valued at approximately $119.30M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Blackrock, Inc. is the largest disclosed holder, reporting approximately $17.84M in TNXP holdings in its latest filing.